Long-Term Infliximab Treatment in Psoriasis Patients: A National Multicentre Retrospective Study.

Clémentine CarletDamien BichardMarie Aleth RichardEmmanuel MahéClémence SaillardEmilie BrenautAlain DupuyLaurent MiséryAxel VillaniDenis JullienEve PuzenatCharlée NardinFrançois Aubinnull Groupe de Recherche Sur le Psoriasis de la Société Française de Dermatologie

Published in: Dermatology research and practice (2020)

We report the efficacy and safety of IFX maintained for up to 12 years in psoriasis patients. The long-term use of IFX was associated with a high BMI confirming the critical role of weight-based dosing for this drug.

Keyphrases

ejection fraction
newly diagnosed
body mass index
prognostic factors
clinical trial
randomized controlled trial
physical activity
emergency department
weight loss
study protocol
quality improvement
double blind
patient reported
electronic health record